1 year return (CAGR)
85.77%
Zynerba Pharmaceuticals Inc Exchange (NASDAQ, USD)
ZYNE
-
0.00 (0.00%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-28.85%
5 year return (CAGR)
-29.28%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
70.12M
Price/Sales
-
Ent value
45.61M
Price/Book
2.42
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-19.92%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.30 |
| Daily high | 1.30 |
| Daily low | 1.30 |
| Daily Volume | 0K |
| 1y analyst estimate | 1.25 |
| Beta | 1.19 |
| EPS (TTM) | -0.74 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ZYNE | S&P500 | |
| Current price drop from All-time high | -96.44% | -8.66% |
| Highest price drop | -99.18% | -56.47% |
| Date of highest drop | 19 May 2023 | 9 Mar 2009 |
| Avg drop from high | -79.84% | -10.68% |
| Avg time to new high | 515 days | 12 days |
| Max time to new high | 2055 days | 1805 days |
News
No items found